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Introduction: Peripheral correlates of age-associated cognitive decline are important
tools in the screening for potentially abnormal courses of cognitive aging. Since salivary
gland function is controlled by the autonomic and central nervous system, associations
between cognitive changes and salivary gland hypofunction were tested in two groups
of middle-aged men in late midlife, who differed substantially with respect to their midlife
performance in verbal intelligence when compared with their performance in young
adulthood.
Materials and Methods: Participants (n = 193) were recruited from the Danish
Metropolit Cohort of men born in 1953. Based on their individual change in performance
in two previously administered intelligence tests, they were allocated to one group of
positive and one group of negative outliers in midlife cognition scores, indicating no
decline versus decline in test performance. All participants underwent a clinical oral
examination including assessments of their dental, periodontal, and mucosal conditions.
Whole and parotid saliva flow rates were measured, and the number of systemic
diseases and medication intake as well as daytime and nocturnal xerostomia were
registered.
Results: Participants with decline in cognitive test performance in midlife had
significantly lower unstimulated whole saliva flow rates, higher prevalence of
hyposalivation and daytime xerostomia and a higher caries experience than participants
with no decline in midlife performance. Daytime and nocturnal xerostomia were
associated with daily intake of medication and alcohol.
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Discussion: Overall, hyposalivation, xerostomia and poor dental status distinguished
a group of men displaying relative decline in cognitive performance from a group of
men without evidence of cognitive decline. Thus, hyposalivation and poor dental health
status may represent potential correlates of age-related cognitive decline in late midlife,
provided that other causes can be excluded.
Keywords: salivary secretion, xerostomia, DMFs index, oral health, age-related changes in cognition, central
autonomic control
INTRODUCTION
Sensitive predictors of different courses of cognitive aging
are important tools in the screening for persons at risk
of transition into an age-associated cognitive disorder.
As central nervous system predictors of subtle cognitive
changes are difficult to identify, it is of interest to find
clinical and peripheral correlates which can be assessed
more easily.
Salivary gland function is under autonomic control and
also regulated by higher order brain centers, many of which
participate in a central autonomic network of connected
brain structures at forebrain, midbrain and brainstem levels
(Pedersen et al., 2012). Thus, it is well-known that for
example mental stimuli or affective states can influence
saliva secretion, and the relation between cognitive processes
and saliva secretion has found use in psychophysiological
studies. The close relationship between the central and the
autonomic nervous system indicates that central autonomic
control pathways may be affected by degenerative processes
that also underlie cognitive deterioration. Changes of autonomic
functions have been observed in patients with Alzheimer’s
disease (Aharon-Peretz et al., 1992; Algotsson et al., 1995),
and it has also been shown that untreated patients with
Parkinson’s disease (Cersósimo et al., 2009) and Alzheimer’s
disease (Ship et al., 1990; Ship and Puckett, 1994) have
lower saliva flow rates than healthy persons. Previous studies
on the potential relation between cognitive decline and
autonomic dysfunction in persons with cognitive disorders
suggest that functional aspects of salivary glands might predict
cognitive decline analogous to cardiovascular correlates that
relate to impaired cognition (Kim et al., 2006; Collins et al.,
2012). Hyposalivation, a condition characterized by abnormal
low unstimulated and/or stimulated whole saliva flow rates
(Sreebny, 2000), and hence also xerostomia (the sensation of
dry mouth) constitute potential autonomic nervous system
correlates of cognitive decline. Hyposalivation may reflect
lowered parasympathetic activity as parasympathetic stimulation
mediates the largest fluid output from the glands (Pedersen et al.,
2012).
The objective of this study was to identify autonomic nervous
system correlates of cognitive decline. We hypothesized that
men displaying decline in cognitive performance in late midlife
have lower saliva flow rates and poorer oral health than
age-matched men with no evidence of decline in cognitive
performance.
MATERIALS AND METHODS
Study Participants
This study was part of a multidisciplinary project on predictors
of cognitive changes in middle-aged men recruited from the
Danish Metropolit Cohort of the Copenhagen Aging and Midlife
Biobank (CAMB) project (Osler et al., 2006; Osler et al., 2013;
Lund et al., 2015). For further details about the recruitment and
selection procedures and previous published papers related to
the project (Hansen et al., 2014; Sørensen et al., 2014, 2016,
Waller et al., 2016). Briefly, all participants were born in 1953,
and selected in 2009 on basis of their performance in two earlier
intelligence tests, the Børge Priens Prøve (BPP) (Teasdale, 2009)
at about age 18 and the Intelligence-Struktur-Test (I-S-T 2000 R)
(Amthauer et al., 2001) at age 56 (Osler et al., 2013; Mortensen
et al., 2014). The correlation between the two tests was found to
be 0.70 with an almost 40-year retest interval (Osler et al., 2013).
Based on the BPP test scores the expected I-S-T 2000 R scores
in midlife were predicted by a regression model. The largest
positive or negative standardized residuals between predicted
and obtained I-S-T 2000 R scores were used to select a group
with no evidence of cognitive decline (group 1) and a group
with an indication of decline in cognitive performance in midlife
(group 2). Exclusion criteria were known medical conditions such
as neurodegenerative or major psychiatric disorders, dementia,
major brain lesions, alcohol or drug abuse. A total number of
195 men participated, and 193 were included. All participants
received verbal and written information about the examinations,
and the project was approved by the ethical committee of the
Capital Region of Denmark (no. H-3-2010-016). All participants
gave written consent. The study was performed following the
STROBE recommendations.
Assessment of Xerostomia and
Measurements of Saliva Flow Rates
All participants were interviewed using a standardized
questionnaire in which current and previous diseases, medication
intake, smoking, alcohol habits, and symptoms of oral dryness
during morning and daytime (daytime xerostomia), and during
night-time (nocturnal xerostomia) were registered. Daytime
xerostomia was rated as described previously (Sørensen et al.,
2014), and nocturnal xerostomia was assessed by questioning
about any symptoms of oral dryness during night-time and/or
frequent wake-ups feeling thirsty, coded into yes (1) or no (0).
Measurements of unstimulated whole saliva (UWS), paraffin-
chewing-stimulated whole saliva (SWS), and citric acid (2%)
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stimulated parotid saliva (SPS) flow rates were performed as
earlier described in detail (Pedersen et al., 1999). UWS was
sampled over a 10-min period, SWS and SPS over a 5-min period.
Samples with values ≤0.10 ml/min for UWS flow rates were
designated as hyposalivation (Pedersen et al., 1999). Since the
frequency of hyposalivation for SWS flow (i.e., ≤0.70 ml/min)
was below 5, it was not further considered for statistical analysis.
Clinical Oral Examination
Any changes of the oral mucosa and presence of oral mucosal
diseases/lesions were registered. Oral hygiene status and the
degree of gingival inflammation were scored at four sites per
tooth on six index teeth (16, 21, 24, 36, 41, and 44) using
the plaque and gingival indices (Pedersen et al., 1999). The
periodontal probing pocket depth was scored on the same index
teeth to assess the presence of periodontitis. The number of
decayed (D), missing (M) and filled (F) surfaces (s) (DMF-s) and
teeth (t) (DMF-t) and the total number of these was expressed as
the DMF-s and -t indices. For analyses we used the DMF-s index.
Third molars were excluded in all calculations.
Statistics
SAS 9.3 (SAS Institute Inc., Cary, NC, United States) and
GraphPad Prism version 6, GraphPad Software, United States,
were used for analyses. Significance of group differences for
categorical variables was calculated by Chi-Square tests and
by Fisher’s exact test when the number of observations was
below five. The number of diseases and medications taken
on a daily basis were coded into: 0 (= none) or 1 (= 1 or
more within the same major category). Ordinal categorical
and continuous data were analyzed with the Wilcoxon Two
Sample Rank Sum Test, as not all variables were assumed
to approximate a normal distribution, except for the BPP
and IST-2000-R cognition scores, which were analyzed by an
unpaired t-test. P-values < 0.05 were considered statistically
significant. Associations between ordinal and/or continuous
variables were tested by Spearman’s rank correlation coefficient
and associations between categorical and continuous variables
were tested by the Kruskal–Wallis Test. When multiple
correlations were tested for the same variable, the alpha level
of significance of 0.05 was adjusted by the Holm-Bonferroni
method for each family of tests. Adjusted P-values ≥0.05
were not considered statistically significant. All tests were two-
sided.
RESULTS
Demographic data and cognitive scores of the two groups have
been reported previously (Hansen et al., 2014; Sørensen et al.,
2014, 2016, Waller et al., 2016). Briefly, the mean (±SD) age was
57.86 ± 0.06 years in group 1 (n = 94) and 58.04 ± 0.08 years
in group 2 (n = 99). The mean number of years of education
differed from 14.06 ± 2.28 in group 1 to 12.65 ± 2.24 years
in group 2 (P < 0.0001). No group difference was found
with respect to the participant’s occupational status. Data were
available from 176 men and 95.5% of them were employed
(95.4% out of 87 in group 1 and 95.5% out of 89 in group 2).
The two groups did not differ significantly with respect to
smoking habits or alcohol consumption (Sørensen et al., 2016).
The cognitive performance scores applied to the number of
participants included in this study also resembled those shown in
the previous report, i.e., the mean BPP score in early adulthood
was 46.0 ± 9.7 for group 1, and 45.4 ± 8.2 for group 2
(P = 0.61), whereas the mean I-S-T 2000 R cognitive scores in
late midlife varied from 42.6 ± 7.4 in group 1 to 21.1 ± 6.0 in
group 2 (P < 0.0001). Occupational status, alcohol and smoking
habits were not significantly correlated with the I-S-T 2000 R
performance scores.
The most frequently reported medical conditions were
musculoskeletal diseases (28.5%), hypertension (29.5%), allergies
(22.8%), and hypercholesterolemia (22.3%) (Table 1). While the
latter three categories were almost evenly distributed between the
two groups, musculoskeletal diseases were about 1.9 times more
prevalent in group 2 (P = 0.01), and gastrointestinal diseases
about 3.3 times more prevalent in group 2 than in group 1
(P = 0.03). None of the disease categories was correlated with
cognitive performance scores or saliva flow rates at adjusted
significance levels.
Intake of lipid-modifying agents (16.6%), agents acting on
the renin-angiotensin system (15%), calcium-channel blockers
(13.5%) and antithrombotic agents (12.4%) was most often
reported. Intake of neurological agents (P = 0.01) and antigout
preparations (P = 0.03) was significantly higher in group 2 than
in group 1 (Table 2). When tested at the adjusted significance
levels, the intake of medication was neither significantly
correlated with I-S-T 2000 R scores nor with saliva flow
rates, except for the intake of diuretics (thiazides), which
was significantly negatively correlated with SWS flow rates
(rs =−0.21, P = 0.003, and adjusted P = 0.046).
The majority of participants displayed saliva flow rates
(ml/min) within normal ranges (Table 3). However, the median
unstimulated whole saliva (UWS) flow rate in group 2 was
19.5% lower than in group 1 (P = 0.01), whereas there were no
significant differences regarding the median chewing-stimulated
(SWS) and citric-acid stimulated (SPS) whole saliva flow rates.
The frequency of hyposalivation was six times higher in group
2 than in group 1 (P = 0.01) (Table 4). Additionally, the total
number of low secretors, i.e., UWS flow rates <0.20 ml/min
was higher in group 2 (P = 0.01). Daytime xerostomia was
reported by 21.8% of all participants with a frequency in
group 2 almost twice as high as in group 1 (P = 0.02).
Nocturnal xerostomia was observed in 23.3% of all participants
with a higher frequency in group 2, but not statistically
significant. Analyses of the inter-relationship between single
parameters of xerostomia showed that there was no significant
correlation between daytime xerostomia and UWS flow rates,
hyposalivation, or low secretion. Neither daytime xerostomia
nor nocturnal xerostomia or hyposalivation were significantly
associated with daily smoking. Testing the same parameters for
correlation with daily alcohol consumption showed that this
was neither significantly correlated to daytime xerostomia nor
hyposalivation, but to nocturnal xerostomia (rs = 0.19, P = 0.01,
and adjusted P = 0.03).
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TABLE 1 | Distribution of diseases reported by the 193 male participants born in 1953.
ICD-10 classification system Group 1
n = 94 (%)
Group 2
n = 99 (%)
All
n = 193 (%)
P-value
Malignant neoplasmsa 3.2 6.1 4.7 0.50
Disorders of the thyroid glandb 0 3 1.6 0.25
Diabetes mellitusc 4.3 3 3.6 0.72
Hypercholesterolemiad 20.2 24.2 22.3 0.50
Depressive episodee 10.6 7.1 8.8 0.38
Persistent mood disorderf 0 4 2.1 0.12
Migraineg 10.6 5.1 7.8 0.15
Essential hypertensionh 30.9 28.3 29.5 0.70
Other cardiac diseasesi 13.8 9.1 11.4 0.30
Allergic and atopic disordersj 23.4 22.2 22.8 0.84
Chronic lower respiratory diseasesk 3.2 6.1 4.7 0.50
Diseases of the digestive systeml 4.3 13.1 8.8 0.03∗
Allergies to medicamentsm 3.2 4 3.6 0.99
Arthropathiesn 4.3 8.1 6.2 0.27
Musculoskeletal diseaseso 20.2 36.4 28.5 0.01∗
Diseases of the genitourinary systemp 3.2 3 3.1 0.99
Psoriasisq 6.4 1 3.6 0.06
List of reported disorders according to the International Classification of Diseases, ICD-10 system (WHO, 2016a): a(C09, C14, C20, C43, C44, C62); b(E03, E05); c(E10,
E11); d(E78.0); e(F32); f(F34); g(G43.0, G43.1); h(I10); i(I22, I49, Q24, Z95, I61, I82); j(J30, L20, L23, T78.1, T78.3); k(J42, J44.9, J45); l(K21, K51, K80, K44, K29,
K40); m(reported allergy to drugs, medicaments and biological substances: Z88); n(M06, M07, M10, D86); o(M15, M48, M50, M51, M76.6, M77.1); p(N20, N40); q(L40).
P-values obtained by Fisher’s exact test or Chi-Square test. ∗P < 0.05.
TABLE 2 | Self-reported daily intake of prescribed medication by the 193 male participants born in 1953.
Medication categories according to the ATC classification system (code) Group 1
n = 94 (%)
Group 2
n = 99 (%)
All
n = 193 (%)
P-value
Proton pump inhibitors (A02BC) 4.3 9.1 6.7 0.18
Medication used in diabetes (A10) 3.2 3 3.1 0.99
Antithrombotic agents (B01A) 12.8 12.1 12.4 0.89
Diuretics, thiazides and potassium (C03AB01) 4.3 6.1 5.2 0.75
Beta blocking agents (C07) 5.3 6.1 5.7 0.82
Calcium channel blockers (C08) 9.6 17.2 13.5 0.12
Agents acting on the renin-angiotensin system (C09) 17 13.1 15 0.45
Lipid modifying agents (C10A) 18.1 15.2 16.6 0.58
Antiinflammatory and antirheumatic agents, NSAIDs (M01A) 3.2 5.1 4.1 0.72
Antigout preparations (M04A) 0 6.1 3.1 0.03∗
Analgesics (N02) 3.2 3 3.1 0.99
Agents acting on the nervous system (N03, N05 and N06) 0 7.1 3.6 0.01∗
Nasal preparations/antihistamines (R01, R06) 6.4 1 3.6 0.06
Drugs for obstructive airway diseases (R03) 3.2 5.1 4.1 0.72
Medications are classified according to the Anatomical Therapeutic Chemical (ATC) Classification System (WHO, 2016b). NSAIDs = non-steroid anti-inflammatory drugs.
P-values obtained by Fisher’s exact test or Chi-Square test. ∗P < 0.05.
TABLE 3 | Median values (ml/min) of unstimulated whole saliva (UWS), chewing-stimulated whole saliva (SWS), and citric-acid stimulated parotid saliva (SPS) flow rates
in group 1 and group 2.
Group 1 Group 2 All P-value
UWS, ml/min 0.41 (0.05–2.02) n = 94 0.33 (0.04–1.5) n = 98 0.36 (0.04–2.02) n = 192 0.01∗
SWS, ml/min 2.61 (0.84–7.99) n = 93 2.26 (0.29–7.47) n = 99 2.51 (0.29–7.99) n = 192 0.21
SPS, ml/min 0.51 (0.10–1.60) n = 94 0.46 (0.04–1.30) n = 97 0.5 (0.04–1.60) n = 191 0.10
P-values for group differences were calculated by Wilcoxon Two Sample Rank Sum test. n: number of participants. ∗P < 0.05.
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TABLE 4 | Prevalence of hyposalivation (UWS ≤ 0.10 ml/min), low secretion
(UWS < 0.20 ml/min), daytime and nocturnal xerostomia in group 1 and 2 and in
the whole study population.
Group 1 (%) Group 2 (%) All (%) P-value
Hyposalivation 2.1 12.2 7.3 0.01∗
Low secretion 13.8 28.6 21.4 0.01∗
Daytime xerostomia 14.9 28.3 21.8 0.02∗
Nocturnal xerostomia 18.1 28.3 23.3 0.09
Analysis of differences between groups was performed by Chi-Square test.
∗P < 0.05.
At adjusted significance levels, there were no associations
between diseases, hyposalivation, low salivary secretion, daytime
or nocturnal xerostomia. The potential xerogenic effect of
medication was also investigated by testing correlations between
intake of the different medications and saliva flow rates
and xerostomia. At the adjusted significance levels, intake of
diuretics (thiazides) was positively correlated to low secretion
(rs = 0.22, P = 0.002, and adjusted P = 0.03), and intake
of proton pump inhibitors was positively correlated with
daytime xerostomia (rs = 0.22, P = 0.002, and adjusted
P = 0.03).
Almost all participants attended their dentist on a regular
basis. The groups differed with respect to the total number of
DMF-s (P = 0.03) (Table 5). The mean score of DMF-s in
group 2 was 11.6% higher than in group 1. Furthermore, the
number of filled tooth surfaces tended to be higher in group
2. The DMF-s was significantly negatively correlated to the
cognitive performance scores (rs = –0.18, P = 0.01, adjusted
P = 0.04).
The two groups did not differ significantly with respect to
the plaque and gingival indices, or the presence of periodontitis
(Table 5). Periodontitis was significantly positively associated
with the GI (rs = 0.32, P < 0.0001).
The most prevalent oral mucosal changes observed in all
participants were fissured (18%) and geographic tongue (9%).
Also, mandibular tori (11%) were common. There were no
differences between groups with regard to the presence of these
mucosal changes or of oral candidosis, which was seen in 4% of
all participants.
DISCUSSION
We have shown that salivary gland function, dental health,
and xerostomia distinguished two groups of middle-aged men,
who differed significantly with respect to midlife cognitive
performance. None of the participants had a clinical diagnosis of
cognitive impairment or any neurodegenerative disorders.
Similar to other autonomic parameters, measures of salivary
gland function can be confounded by systemic diseases,
medication and health-compromising life-style habits. At
adjusted significance levels, diseases, smoking and daily alcohol
intake were not associated with hyposalivation, daytime
xerostomia or low saliva flow rates. However, intake of thiazides
remained significantly positively correlated with low secretion,
i.e., UWS < 0.2 ml/min, and negatively related to SWS flow
rates, which is in line with previous observations (Nederfors
et al., 1989; Smidt et al., 2010). Moreover, intake of proton pump
inhibitors was associated with daytime xerostomia. Previous
results are conflicting regarding the impact of, for example, the
proton pump inhibitor Omeprazole R© on salivary gland function
(Teare et al., 1995; Namiot et al., 2001). Nocturnal xerostomia
was associated with daily intake of alcohol indicating that
nocturnal xerostomia itself has limited potential as correlate of
age-related changes in cognition.
Previous studies have also reported an association between
poor oral and dental health and low cognitive performance
in middle-aged adults (Stewart et al., 2008) and older adults
(Stewart and Hirani, 2007). We showed that the caries load
was higher in men with lower cognitive performance in midlife,
and that the DMF-s score was negatively correlated to midlife
cognitive performance. Our findings are in line with those
from a previous study on adults in earlier midlife (Sabbah
and Sheiham, 2010), apart from the fact that almost all of the
participants in our study, including those with low cognitive
scores, visited the dentist on a regular basis, and caries lesions
were treated as evidenced by the high number of filled surfaces
in group 2. There were no differences in the plaque and
gingival indices between groups indicating comparable oral
hygiene habits in both groups. Consequently, the higher caries
prevalence found in men with decline in cognitive performance
is more likely related to salivary gland dysfunction than to
TABLE 5 | Dental and oral health measures in group 1 and 2 as well as in the whole study population.
Dental status Group 1
n = 94
Group 2
n = 99
All
n = 193
P-value
No. of DMFs 37.96 (22.04) 42.94 (19.26) 40.51 (20.76) 0.03∗
No. of decayed surfaces 0.21 (0.53) 0.54 (1.84) 0.38 (1.38) 0.51
No. of missing surfaces 6.33 (16.45) 6.16 (10.73) 6.24 (13.78) 0.71
No. of filled surfaces 31.41 (16.15) 36.09 (16.43) 33.81 (16.42) 0.05
Plaque index 0.65 (0.74) 0.81 (0.89) 0.73 (0.82) 0.20
Gingival index 0.54 (0.64) 0.6 (0.74) 0.57 (0.69) 0.62
Chronic periodontitis 12.8% 15.2% 14% 0.63
DMF-s index: Number of decayed, missing, filled surfaces given as mean values and standard deviation (SD). Wilcoxon Two Sample Rank Sum test was used for
calculation of P-values for group differences within DMF-s scores, and the plaque and gingival indices. Significance of difference within the prevalence of periodontitis
was tested by Chi-Square test. n: number of participants included. ∗P < 0.05.
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poor oral hygiene, as saliva is essential for the maintenance of
oral health. Hyposalivation was more common and the UWS
flow rates lower in group 2 than in group 1. Parasympathetic
nerve impulses induce the largest fluid secretion from the
salivary glands (Pedersen et al., 2012), and salivary gland
hypofunction that cannot be ascribed to medication intake,
trauma or behavioral factors may be of neurogenic origin.
We speculate that dysregulation of the central autonomic
network, i.e., neuronal circuits that include limbic system
or cortical structures involved in regulation of preganglionic
parasympathetic activity, may lead to altered parasympathetic
outflow and reduced saliva secretion. These speculations are
supported by a study showing that the parasympathetic system
was affected in persons with mild cognitive impairment and an
association between impaired autonomic functions and poorer
cognitive performance (Collins et al., 2012). On the other hand,
the low frequency of hyposalivation regarding stimulated whole
saliva indicates that the ability of the salivary glands to respond
adequately to masticatory and gustatory stimuli was unaltered in
both groups. Accordingly, parasympathetic mechanisms related
to the formation of unstimulated saliva could be more prone to be
affected by central changes. The preganglionic parasympathetic
innervation of the minor mucous and sublingual salivary glands
as well as the submandibular glands, which contribute most
to unstimulated saliva, originates from the superior salivatory
nucleus in the brainstem. Studies on the rodent brain have
shown that cortical and subcortical structures, which engage
in central autonomic control, project to the superior salivatory
nucleus (Jansen et al., 1992; Hübschle et al., 1998). These
identified structures included telencephalic components such as
the insular cortex (Hübschle et al., 1998), the bed nucleus of
the stria terminalis and the central nucleus of the amygdala
(Jansen et al., 1992; Hübschle et al., 1998). Together with
regions of the medial prefrontal cortex, they engage “in high-
order processing of viscerosensory information and initiation
of integrated autonomic responses” (Benarroch, 1993). These
observations may provide a neuroanatomical substrate for a
relation between higher cognitive and affective processes and
salivary gland function, which in turn could be reflected by
changes in salivary flow and composition in association with
altered cognitive or affective states.
The present study has the strength that it is longitudinal in its
design and includes a well-characterized, large cohort of same age
and gender. While the latter circumvents confounding by these
two factors, it implicates on the other hand that further research
is necessary to test the generalizability of our findings in a study
group representative of a broader population.
CONCLUSION
Hyposalivation, xerostomia and poor dental status distinguished
a group of men displaying relative decline in cognitive
performance from a group of men without evidence of cognitive
decline. These findings could not be explained by age per se, since
all participants had the same age, nor unhealthy behavior such
as smoking, alcohol consumption or avoidance of regular dental
check-ups. Neither is it likely that disease or medication alone
is responsible for the group differences. Our findings suggest a
linkage between altered central autonomic control pathways and
altered central pathways involved in cognitive processing.
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